Research statistics
Vasoactive Intestinal Peptide (VIP) research: publications and trials
At a glance
Publications, all years
7,193
Since 1971
Publications in 2026 so far
39
Through November 15, 2026
Human clinical research
12.2%
865 of 7,107 classified
Registered clinical trials
15
ClinicalTrials.gov
Randomized controlled trials
46
Publications reporting an RCT in people
Systematic reviews and meta-analyses
3
Preclinical studies
81.8%
4,736 animal · 1,060 in vitro · 17 computational
Records that only mention it
7,088
Not counted above
Status in the library: Research only. 86 publications are not yet classified by study type.
What to keep in mind
- More than 70% of the indexed publications are animal, cell or computational studies.
- Some completed trials have neither posted results nor a linked results publication.
- The body makes this molecule itself, so much of its literature is physiology rather than research on it as a compound.
Publications by year
Vasoactive Intestinal Peptide (VIP) publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 1971 | 0 | 1 | 0 | 0 | 1 |
| 1972 | 0 | 1 | 0 | 0 | 1 |
| 1973 | 1 | 3 | 0 | 2 | 6 |
| 1974 | 0 | 3 | 1 | 0 | 4 |
| 1975 | 2 | 1 | 1 | 3 | 7 |
| 1976 | 5 | 14 | 0 | 4 | 23 |
| 1977 | 11 | 28 | 0 | 3 | 42 |
| 1978 | 15 | 45 | 0 | 4 | 64 |
| 1979 | 13 | 46 | 2 | 3 | 64 |
| 1980 | 18 | 90 | 4 | 2 | 114 |
| 1981 | 15 | 72 | 2 | 2 | 91 |
| 1982 | 14 | 83 | 2 | 7 | 106 |
| 1983 | 26 | 146 | 4 | 9 | 185 |
| 1984 | 33 | 165 | 5 | 1 | 204 |
| 1985 | 21 | 204 | 3 | 4 | 232 |
| 1986 | 24 | 215 | 10 | 1 | 250 |
| 1987 | 29 | 203 | 3 | 6 | 241 |
| 1988 | 29 | 250 | 30 | 9 | 318 |
| 1989 | 24 | 252 | 8 | 4 | 288 |
| 1990 | 26 | 232 | 6 | 4 | 268 |
| 1991 | 23 | 223 | 8 | 4 | 258 |
| 1992 | 27 | 229 | 1 | 4 | 261 |
| 1993 | 29 | 231 | 7 | 2 | 269 |
| 1994 | 20 | 247 | 4 | 7 | 278 |
| 1995 | 25 | 209 | 13 | 3 | 250 |
| 1996 | 26 | 230 | 18 | 3 | 277 |
| 1997 | 19 | 174 | 4 | 1 | 198 |
| 1998 | 18 | 194 | 11 | 3 | 226 |
| 1999 | 15 | 138 | 11 | 2 | 166 |
| 2000 | 19 | 155 | 8 | 2 | 184 |
| 2001 | 12 | 126 | 9 | 1 | 148 |
| 2002 | 18 | 113 | 9 | 2 | 142 |
| 2003 | 11 | 131 | 13 | 0 | 155 |
| 2004 | 14 | 99 | 12 | 1 | 126 |
| 2005 | 12 | 92 | 12 | 0 | 116 |
| 2006 | 10 | 120 | 11 | 1 | 142 |
| 2007 | 14 | 99 | 19 | 5 | 137 |
| 2008 | 14 | 85 | 14 | 3 | 116 |
| 2009 | 13 | 73 | 4 | 0 | 90 |
| 2010 | 18 | 77 | 8 | 0 | 103 |
| 2011 | 11 | 62 | 12 | 1 | 86 |
| 2012 | 13 | 52 | 12 | 2 | 79 |
| 2013 | 16 | 64 | 5 | 3 | 88 |
| 2014 | 13 | 64 | 6 | 2 | 85 |
| 2015 | 12 | 44 | 5 | 0 | 61 |
| 2016 | 13 | 41 | 6 | 0 | 60 |
| 2017 | 7 | 35 | 2 | 1 | 45 |
| 2018 | 17 | 49 | 6 | 1 | 73 |
| 2019 | 13 | 45 | 7 | 0 | 65 |
| 2020 | 13 | 41 | 5 | 0 | 59 |
| 2021 | 18 | 36 | 8 | 2 | 64 |
| 2022 | 12 | 45 | 9 | 1 | 67 |
| 2023 | 13 | 38 | 7 | 3 | 61 |
| 2024 | 10 | 35 | 2 | 1 | 48 |
| 2025 | 11 | 39 | 6 | 6 | 62 |
| 2026 (to date) | 10 | 24 | 3 | 2 | 39 |
Study types
| Animal study | 4,736 |
|---|---|
| In vitro study | 1,060 |
| Observational human study | 401 |
| Review | 375 |
| Case report | 222 |
| Other clinical trial | 196 |
| Not yet classified | 86 |
| Editorial, letter or other | 51 |
| Randomized controlled trial | 46 |
| Computational study | 17 |
| Systematic review | 3 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Gastrointestinal | 1,921 |
|---|---|
| Neurological and mental health | 1,837 |
| Endocrinology | 1,347 |
| Immune system | 892 |
| Cardiovascular | 766 |
| Oncology | 703 |
| Reproductive and sexual health | 441 |
| Musculoskeletal | 413 |
| Metabolic health | 274 |
| Tissue repair | 180 |
| Antimicrobial and infectious disease | 164 |
| Dermatology | 155 |
Registered clinical trials
1 of 7 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 10 · Terminated: 2 · Active, not recruiting: 1 · No longer available: 1 · Withdrawn: 1
Phase not applicable: 6 · Phase 1: 1 · Phase 2: 3 · Phase 2 / Phase 3: 2 · Phase 3: 3
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Vasoactive intestinal Peptide as a diagnostic or prognostic biomarker in multiple sclerosis: A systematic review.
Multiple sclerosis and related disorders · July 5, 2026 · Systematic review · cited 0 times · open access
PMID 42447728 · DOI 10.1016/j.msard.2026.107377 · Reviews and meta-analyses
- Retinal VIP-amacrine cells: their development, structure, and function.
Eye (London, England) · December 8, 2023 · Systematic review · cited 9 times · open access
PMID 38066110 · DOI 10.1038/s41433-023-02844-x · Reviews and meta-analyses
- Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology · March 1, 2019 · Systematic review · cited 24 times
PMID 31127985 · Reviews and meta-analyses
- Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19.
Medical principles and practice : international journal of the Kuwait University, Health Science Centre · January 27, 2025 · Randomized controlled trial · cited 7 times · open access
PMID 39870064 · DOI 10.1159/000543773 · Human clinical research
- Hemostatic mechanism of Jianpi Yiqi Shexue decoction in treatment of immune thrombocytopenia.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · June 1, 2024 · Randomized controlled trial · cited 1 times · open access
PMID 38767638 · DOI 10.19852/j.cnki.jtcm.20240423.003 · Human clinical research
- Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
The Lancet. Respiratory medicine · June 19, 2023 · Randomized controlled trial · cited 19 times · open access
PMID 37348524 · DOI 10.1016/s2213-2600(23)00147-9 · Human clinical research
- The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial.
Critical care medicine · August 29, 2022 · Randomized controlled trial · cited 28 times · open access
PMID 36044317 · DOI 10.1097/ccm.0000000000005660 · Human clinical research
- PACAP38- and VIP-induced cluster headache attacks are not associated with changes of plasma CGRP or markers of mast cell activation.
Cephalalgia : an international journal of headache · November 25, 2021 · Randomized controlled trial · cited 27 times
PMID 34822741 · DOI 10.1177/03331024211056248 · Human clinical research
- Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial.
JAMA network open · August 2, 2021 · Randomized controlled trial · cited 81 times · open access
PMID 34357396 · DOI 10.1001/jamanetworkopen.2021.18543 · Human clinical research
- The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache.
Cephalalgia : an international journal of headache · September 22, 2020 · Randomized controlled trial · cited 35 times
PMID 32962406 · DOI 10.1177/0333102420940689 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Type 2 innate lymphoid cells control eosinophil homeostasis.
Nature · September 15, 2013 · Animal study · cited 1,068 times · open access
PMID 24037376 · DOI 10.1038/nature12526 · Animal studies
- International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.
Pharmacological reviews · June 1, 1998 · Review · cited 765 times · open access
PMID 9647867 · Reviews and meta-analyses
- Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons.
Nature neuroscience · March 6, 2005 · Animal study · cited 764 times · open access
PMID 15750589 · DOI 10.1038/nn1419 · Animal studies
- Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide.
Neuron · April 1, 1992 · Animal study · cited 745 times
PMID 1314625 · DOI 10.1016/0896-6273(92)90101-i · Animal studies
- Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.
Nature · October 1, 1988 · Animal study · cited 608 times
PMID 2845276 · DOI 10.1038/335639a0 · Animal studies
Latest publications
- VIP-Mediated Syndromes: Contrasting Presentations and Multidisciplinary Management of Two Rare Neuroendocrine Tumors.
ACG case reports journal · October 28, 2026 · Case report · cited 0 times · open access
PMID 42953880 · DOI 10.14309/crj.0000000000002382 · Human clinical research
- Programmable Engineered Living Vehicles as Autonomous Biofactories for Synergistic Osteomyelitis Management and Bone Regeneration.
Advanced materials (Deerfield Beach, Fla.) · October 26, 2026 · Animal study · cited 0 times
PMID 42929733 · DOI 10.1002/adma.75118 · Animal studies
- Living Donor Liver Transplantation for Vasoactive Intestinal Peptide-Secreting Tumors with Watery Diarrhea, Hypokalemia, and Achlorhydria Syndrome Resulting from Transformation of a Nonfunctional Pancreatic Neuroendocrine Tumor with Multiple Liver Metastases: A Case Report.
Surgical case reports · October 10, 2026 · Case report · cited 0 times · open access
PMID 42889871 · DOI 10.70352/scrj.cr.26-0465 · Human clinical research
- Composite pheochromocytoma-ganglioneuroma secreting vasoactive intestinal peptide.
Endocrinology, diabetes & metabolism case reports · October 1, 2026 · Case report · cited 0 times · open access
PMID 42825457 · DOI 10.1530/edm-25-0184 · Human clinical research
- Influence of exogenous glucagon-like peptide 2 on mechanisms of enteric neurotransmitter-mediated vasorelaxation in the isolated bovine mesenteric artery and vein.
Physiological reports · October 1, 2026 · Animal study · cited 0 times · open access
PMID 42855814 · DOI 10.14814/phy2.71134 · Animal studies
- Serum VIP and IL-1β Levels Are Associated With Anxiety and Depression in Patients With Parkinson's Disease: A Cross-Sectional Study.
Brain and behavior · September 1, 2026 · Observational human study · cited 0 times · open access
PMID 42677804 · DOI 10.1002/brb3.71742 · Human clinical research
- Intranasal delivery of a vasoactive intestinal peptide-based circRNA vaccine induces systemic and mucosal immunity against RSV in mice.
Molecular therapy : the journal of the American Society of Gene Therapy · August 19, 2026 · Animal study · cited 0 times
PMID 42619264 · DOI 10.1016/j.ymthe.2026.08.025 · Animal studies
- VIPoma Presenting With Obstructive Jaundice: A Case Report.
Journal of the ASEAN Federation of Endocrine Societies · August 6, 2026 · Case report · cited 0 times · open access
PMID 42802744 · DOI 10.15605/jafes.041.02.6165 · Human clinical research
- Effects of Biling Weitong granules on gastrointestinal motility and gastrointestinal hormones levels in rats with functional dyspepsia.
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · August 1, 2026 · Animal study · cited 0 times · open access
PMID 42639771 · DOI 10.19852/j.cnki.jtcm.2026.04.007 · Animal studies
- HSV-1 Infection Differentially Modulates NPY and VIP Neuropeptide Expression in the Mouse Brain and in Human Neuronal Cells.
International journal of molecular sciences · July 28, 2026 · Animal study · cited 0 times · open access
PMID 42589390 · DOI 10.3390/ijms27156735 · Animal studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Aviptadil; Vasoactive Intestinal Peptide
((TITLE_ABS:"Aviptadil" OR CHEM:"Aviptadil") OR (TITLE_ABS:"Vasoactive Intestinal Peptide" OR CHEM:"Vasoactive Intestinal Peptide")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Vasoactive Intestinal Peptide (VIP) research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/vip